Treatment of myoclonic epilepsies of childhood, adolescence, and adulthood.
Medina
Marco T
MT
National Autonomous University of Honduras, Tegucigalpa, Honduras.
Martínez-Juárez
Iris E
IE
Durón
Reyna M
RM
Genton
Pierre
P
Guerrini
Renzo
R
Dravet
Charlotte
C
Bureau
Michelle
M
Perez-Gosiengfiao
Katerina Tanya
KT
Amador
Claudia
C
Bailey
Julia N
JN
Chaves-Sell
Franz
F
Delgado-Escueta
Antonio V
AV
D000293:Adolescent; D000328:Adult; D000465:Algorithms; D000927:Anticonvulsants / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D004831:Epilepsies, Myoclonic / Q000145:classification / Q000150:complications / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008137:Longitudinal Studies; D008297:Male; D020190:Myoclonic Epilepsy, Juvenile / Q000145:classification / Q000188:drug therapy* / Q000209:etiology; D011788:Quality of Life; D012196:Review Literature as Topic; D012307:Risk Factors; D012640:Seizures / Q000188:drug therapy; D016896:Treatment Outcome
D000927:Anticonvulsants